Senseonics Holdings, Inc. Reports First Quarter Financial Results
Provided By GlobeNewswire
Last update: May 8, 2025
Q1 Revenue of $6.3 million, growth year over year of 24%
Partnership with Sequel integrates twiist™ automated insulin delivery (AID) system with Eversense® 365 one-year continuous glucose monitor (CGM); twiist with Eversense 365 launch expected in Q3
Read more at globenewswire.com
